Pharmacology and mechanisms of action of diphenylhydantoin.
D000086:Acetazolamide / Q000494:pharmacology; D000818:Animals; D000927:Anticonvulsants / Q000378:metabolism / Q000494:pharmacology*; D001692:Biological Transport / Q000187:drug effects; D001923:Brain Chemistry / Q000187:drug effects; D004827:Epilepsy / Q000188:drug therapy; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects; D007082:Ileum / Q000187:drug effects; D008099:Liver / Q000187:drug effects; D008564:Membrane Potentials / Q000187:drug effects; D010672:Phenytoin / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D011188:Potassium / Q000097:blood / Q000134:cerebrospinal fluid; D051381:Rats; D011955:Receptors, Drug; D012964:Sodium / Q000097:blood / Q000134:cerebrospinal fluid; D013116:Spinal Cord / Q000187:drug effects; D009435:Synaptic Transmission / Q000187:drug effects; D014293:Trimethadione / Q000494:pharmacology
D000927:Anticonvulsants; D011955:Receptors, Drug; D010672:Phenytoin; D012964:Sodium; D000086:Acetazolamide; D014293:Trimethadione; D011188:Potassium